Exane Derivatives’s Vinco Ventures, Inc. Common Stock BBIG Stock Holding History
Bought
Maintained
Sold
Other funds holding BBIG
Exane Derivatives's BBIG Position: Q2 2022 in Review
Exane Derivatives sold out of Vinco Ventures, Inc. Common Stock (BBIG) in Q2 2022, closing a stake of 1,958 shares — an estimated $85.2K sold.
Exane Derivatives first reported a position in BBIG in Q1 2022 and held it in 1 quarter. The position peaked at $85.2K in Q1 2022. 88 funds tracked by Wall St. Rank hold BBIG as of Q2 2022.
- Exane Derivatives reported no remaining Vinco Ventures, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
- Exane Derivatives sold 1,958 Vinco Ventures, Inc. Common Stock shares in Q2 2022, an estimated $85.2K.
- Exane Derivatives first reported a position in Vinco Ventures, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
- Exane Derivatives's Vinco Ventures, Inc. Common Stock position peaked at $85.2K in Q1 2022.
- 88 funds tracked by Wall St. Rank held Vinco Ventures, Inc. Common Stock as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.